Warning on risks: Financial contracts for difference are complex instruments and are associated with a high risk of rapid financial losses due to leverage. On 76.44% of retail investor accounts, financial losses occur when trading financial contracts for difference with this provider. You should consider whether you understand how financial contracts for difference work, and whether you can afford to take the high risk of suffering financial losses. Please read the Risk Disclosures.

Market analysis and news

Get an overview of current market developments with regular analysis from our analysts. We offer a detailed view of key events, economic indicators and investment opportunities. Follow the development of the markets with us and make decisions based on data and experience.

Study

How We Went From Savers to Investors

35 Years Since the Beginning of Voucher Privatization in Czechoslovakia

23/2/2022

HOW PHARMACEUTICS ARE DOING THIS YEAR

Pharmaceutical industry is one of the biggest industries in the world. It is also fast and constantly growing sector, as it increased from valuation of 390 billion U.S. dollars in 2001 to the total global market valuation at 1,27 trillion U.S. dollars in 2020. With its constant uptrend, it is projected that industry will be worth 1,70 trillion U.S. dollars by the end of 2025. 

26/1/2022

Development of new broad-spectrum vaccines: Novavax and Valneva

Vaccines from Novavax and Valneva have a promising future, according to preliminary estimates. Several countries are showing interest and approving the newest vaccines on the market, also due to the spread of the Omikron mutation, which is up to 3 times more contagious than Delta. Scientists even claim that there are other mutations. Some countries are already making vaccination compulsory or bringing in tougher measures for the unvaccinated as the situation in hospitals worsens.

20/12/2021

The second year of covid: China's economy is recovering best, followed by the United States ahead of the European Union

For the second year in a row, the global economy is struggling to cope with the negative effects of the coronavirus pandemic. According to Ozios' analysis, China is doing best among the world's largest economic centres. Its growth this year may climb to the pace that the world's most populous country was used to at the beginning of the last decade. The United States has already surpassed the pre-pandemic level, and the European Union is likely to do so next year.

18/11/2021

The Vaccine Victors – Where are They Now?

With the rise of COVID-19, vaccine makers fought in the pharmaceutical battleground, to gain national trust for its vaccine effectiveness and safety. The outbreak of the coronavirus pandemic incentivized multiple companies to develop vaccines, including Novavax, Sputnik and GlaxoSmithKline (GSK), but generally speaking, four vaccine makers came out on top to mass produce COVID-19 immunization; Johnson & Johnson, Pfizer/BioNTech, Moderna and AstraZeneca. But, how are the vaccine victors performing lately, now that COVID-19 has hit the brakes?

Latest analyses